Moon J. Noh, Ph.D.
Chief Executive Officer
- TG-C US FDA 임상1, 2상 완료
- 서울대 미생물학 학사 ('89) / 카이스트 생명과학 박사 ('95)
Sung Han, Ph,D.
Chief Executive Officer
- 코오롱인더스트리 미래기술원장 ('18~현재)
- Eastman Chemical Company, Technology Director ('14~'17)
- BS-Material Science & Engineering and Nuclear Engineering, University of California, Berkeley, CA
- PhD-Nuclear Engineering, University of California, Berkeley, CA
권순욱
Vice President
- Kolon TissueGene, Inc. CFO ('17~현재)
- (주)코오롱 경영관리실 상무 ('04~'17)
- (주)대우 국제금융부 ('93~'00)
- 고려대 경제학 학사 ('92)
김정인
Chief Financial Officer
- Kolon TissueGene, Inc.('21~현재)
- ㈜ 코오롱 경영관리실('13~'21)
- 국민대학교 수학과 학사('02)
Sun Jin Kim, Ph,D.
Chief Medical Officer
- Kolon TissueGene, Inc., Chief Medical Officer (’21 ~ 현재)
- Platbio Inc. 대표이사 ('18 ~ 현재)
- Executive Vice President, Hanmi Pharm Co., Ltd ('17~'18)
- Seoul National University College of Medicine, Seoul, MD
- Seoul National University Graduate School, Seoul, PHD, Medical Science